iShares Biotechnology ETF (IBB)

iShares Biotechnology ETF (IBB $173.99)
- $173.99 P/E (TTM): 20.63X Cap: $8.36B
- View IBB Profile
- View Questions on IBB

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Intuitive Surgical Inc. (ISRG $451.29)
- $451.29 P/E (TTM): 59.62X Cap: $165.34B
- View ISRG Profile
- View Questions on ISRG
Vertex Pharmaceuticals Incorporated (VRTX $436.59)
- $436.59 P/E (TTM): 28.86X Cap: $111.09B
- View VRTX Profile
- View Questions on VRTX
AbbVie Inc. (ABBV $205.12)
- $205.12 P/E (TTM): 88.3X Cap: $362.80B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $226.16)
- $226.16 P/E (TTM): 21.23X Cap: $544.73B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $903.02)
- $903.02 P/E (TTM): 40.39X Cap: $853.19B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $112.56)
- $112.56 P/E (TTM): 16.36X Cap: $278.16B
- View MRK Profile
- View Questions on MRK
iShares Biotechnology ETF (IBB $173.99)
- $173.99 P/E (TTM): 20.63X Cap: $8.36B
- View IBB Profile
- View Questions on IBB
IDEXX Laboratories Inc. (IDXX $569.01)
- $569.01 P/E (TTM): 44.58X Cap: $45.24B
- View IDXX Profile
- View Questions on IDXX
Halozyme Therapeutics Inc. (HALO $68.41)
- $68.41 P/E (TTM): 27.39X Cap: $8.24B
- View HALO Profile
- View Questions on HALO
Incyte Corporation (INCY $96.22)
- $96.22 P/E (TTM): 15.26X Cap: $19.28B
- View INCY Profile
- View Questions on INCY
Catalyst Pharmaceuticals Inc. (CPRX $25.64)
- $25.64 P/E (TTM): 15.54X Cap: $3.13B
- View CPRX Profile
- View Questions on CPRX
Gilead Sciences CDR (CAD Hedged) (GILD $27.12)
- $27.12 P/E (TTM): 362.21X Cap: $233.87B
- View GILD Profile
- View Questions on GILD

Q: We have accumulated 11 healthcare stocks and 1 ETF, While LLY and ISRG are at half positions the rest are at initial 25% positions. Please advise [help!] us get to a more concentrated portfolio with a 3+ year horizon for reasonable opportunities in healthcare

Read Answer Asked by sam on January 13, 2026

iShares Biotechnology ETF (IBB $173.99)
- $173.99 P/E (TTM): 20.63X Cap: $8.36B
- View IBB Profile
- View Questions on IBB
State Street SPDR S&P Biotech ETF (XBI $136.39)
- $136.39 P/E (TTM): 17.2X Cap: $8.75B
- View XBI Profile
- View Questions on XBI
Natera Inc. (NTRA $205.42)
- $205.42 Cap: $29.11B
- View NTRA Profile
- View Questions on NTRA
ARK Genomic Revolution ETF (ARKG $30.71)
- $30.71 P/E (TTM): 27.48X Cap: $1.03B
- View ARKG Profile
- View Questions on ARKG
Catalyst Pharmaceuticals Inc. (CPRX $25.64)
- $25.64 P/E (TTM): 15.54X Cap: $3.13B
- View CPRX Profile
- View Questions on CPRX

Q: It looks like biotech stocks are on a tear, especially those that may benefit from AI. Do you have any names that you might recommend? I'm considering the Arkg fund but I don't quite trust Cathy Woods after losing money on the Arkk fund in 2021. Thank you,

Jason

Read Answer Asked by Jason on February 18, 2025

Biogen Inc. (BIIB $185.95)
- $185.95 P/E (TTM): 20.13X Cap: $27.28B
- View BIIB Profile
- View Questions on BIIB
Gilead Sciences Inc. (GILD $133.29)
- $133.29 P/E (TTM): 20.33X Cap: $165.46B
- View GILD Profile
- View Questions on GILD
Illumina Inc. (ILMN $131.98)
- $131.98 P/E (TTM): 24.59X Cap: $20.04B
- View ILMN Profile
- View Questions on ILMN
AbbVie Inc. (ABBV $205.12)
- $205.12 P/E (TTM): 88.3X Cap: $362.80B
- View ABBV Profile
- View Questions on ABBV
Abbott Laboratories (ABT $92.72)
- $92.72 P/E (TTM): 26.02X Cap: $167.19B
- View ABT Profile
- View Questions on ABT
Eli Lilly and Company (LLY $903.02)
- $903.02 P/E (TTM): 40.39X Cap: $853.19B
- View LLY Profile
- View Questions on LLY
Novo Nordisk A/S (NVO $39.42)
- $39.42 P/E (TTM): 11.21X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
iShares Biotechnology ETF (IBB $173.99)
- $173.99 P/E (TTM): 20.63X Cap: $8.36B
- View IBB Profile
- View Questions on IBB
State Street SPDR S&P Biotech ETF (XBI $136.39)
- $136.39 P/E (TTM): 17.2X Cap: $8.75B
- View XBI Profile
- View Questions on XBI
First Trust NYSE Arca Biotechnology ETF (FBT $35.73)
- $35.73 P/E (TTM): 27.89X Cap: $3M
- View FBT Profile
- View Questions on FBT

Q: Hi 5i, can you give me the names of 4 or 5 large cap pharmaceutical companies that are buyable now. Also I'm looking for 4 or 5 Biotech companies with one drug in the market making money and maybe something in the pipeline that looks like it has a good future? for example TGTX.

Read Answer Asked by Mark on January 09, 2025